Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Antígeno asociado tumor")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 5320

  • Page / 213
Export

Selection :

  • and

The identification of human tumour antigens : current status and future developmentsMILES, Amanda K; MATHAROO-BALL, Balwir; GENG LI et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 8, pp 996-1003, issn 0340-7004, 8 p.Article

CEAS: cis-regulatory element annotation systemSHIN, Hyunjin; TAO LIU; MANRAI, Arjun K et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 19, pp 2605-2606, issn 1367-4803, 2 p.Article

Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in CosmcTONGZHONG JU; LANNEAU, Grainger S; LASZIK, Zoltan et al.Cancer research (Baltimore). 2008, Vol 68, Num 6, pp 1636-1646, issn 0008-5472, 11 p.Article

Remarques, critiques sur la signification des marqueurs tumoraux = About the signification of tumoral markersSTEFFEN, A.Lyon Méditerranée médical. Médecine du sud-est. 1989, Vol 25, Num 5-6, issn 0766-5466, 12329-12334 [4 p.]Article

A Novel Tumor Antigen Derived from Enhanced Degradation of Bax Protein in Human CancersTRINDADE NUNES, Cláudia; MINERS, Kelly L; DOLTON, Garry et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 16, pp 5435-5444, issn 0008-5472, 10 p.Article

Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigenBOSS, Cristina N; GRÜNEBACH, Frank; BRAUER, Katharina et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3347-3355, issn 1078-0432, 9 p.Article

Immunothérapie et vaccination antitumorale : le point sur ces nouvelles techniques = Immunotherapy and antitumoral vaccinationBONVALLOT, Véronique.Biofutur (Puteaux). 2003, Vol 238, pp 34-37, issn 0294-3506, 4 p.Article

Clinical evaluation of CA72-4 immunoradiometric assay for serum TAG-72 antigen in patients with carcinomaOHUCHI, N; GERO, E; MORI, S et al.Journal of tumor marker oncology. 1990, Vol 5, Num 1, pp 1-10, issn 0886-3849Article

A tumor-associated antigen in the scirrhous gastric carcinoma cell line MK-01 defined by monoclonal antibody S202YOKOTA, T; MASUKO, T; YAMAGUCHI, T et al.Japanese journal of surgery. 1989, Vol 19, Num 4, pp 452-458, issn 0047-1909, 7 p.Article

Importance of pH in defining the specificity and clinical utility of monoclonal antibodies ― an evaluation of two anti-CA 19-9 monoclonal antibodiesVAN HEEL, A; SURESH, M. R.Cancer letters. 1989, Vol 48, Num 2, pp 85-88, issn 0304-3835, 4 p.Article

A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3LYUBSKY, S; MADARIAGA, J; LOZOWSKI, M et al.American journal of clinical pathology. 1988, Vol 89, Num 2, pp 160-167, issn 0002-9173Article

Tumor markersScandinavian journal of clinical & laboratory investigation. Supplement. 1988, Vol 48, pp 35-49, issn 0085-591X, suppl. 190Conference Paper

Organisation du gène p53 chez l'homme. I. Clonage moléculaire du gène p53BUKHMAN, V. L; NINKINA, N. N; CHUMAKOV, P. M et al.Genetika. 1987, Vol 23, Num 9, pp 1547-1554, issn 0016-6758Article

A mutant chaperone converts a wild-type protein into a tumor-specific antigenSCHIETINGER, Andrea; PHILIP, Mary; YOSHIDA, Barbara A et al.Science (Washington, D.C.). 2006, Vol 314, Num 5797, pp 304-308, issn 0036-8075, 5 p.Article

Les vaccins thérapeutiques : L'arsenal biotech contre les cancers = Therapeutic vaccinesMOINGEON, Philippe.Biofutur (Puteaux). 2001, Num 212, pp 54-57, issn 0294-3506Article

Clinical experience with CA-50 in the serum of carcinoma patientsHABIB, N. A; HERSHMAN, M. J; KELLY, S. B et al.European journal of surgical oncology. 1989, Vol 15, Num 4, pp 361-366, issn 0748-7983Article

Tumour marker immunoreactivity in adenocarcinomaELLIS, I. O; HITCHCOCK, A.Journal of clinical pathology. 1988, Vol 41, Num 10, pp 1064-1067, issn 0021-9746Article

Efficient Identification of a Novel Cancer/Testis Antigen for Immunotherapy Using Three-Step Microarray AnalysisYOKOE, Takeshi; TANAKA, Fumiaki; MIMORI, Koshi et al.Cancer research (Baltimore). 2008, Vol 68, Num 4, pp 1074-1082, issn 0008-5472, 9 p.Article

Different forms of helper tolerance to carcinoembryonic antigen : Ignorance and regulationPICKFORD, Wendy J; WATSON, Angus J. M; BARKER, Robert N et al.Clinical cancer research. 2007, Vol 13, Num 15, pp 4528-4537, issn 1078-0432, 10 p., 1Article

Progress and prospects for human cancer vaccinesCOLE, J. S; GRUBER, J.Journal of the National Cancer Institute. 1992, Vol 84, Num 1, pp 18-23, issn 0027-8874Article

Mise au point sur les marqueurs tumoraux = Tumoral markersCATIMAL, G; PASQUIER, J; BACHET, P et al.Journal de médecine de Lyon (Lyon. 1864). 1989, Vol 70, Num 1443, pp 11-15, issn 0021-7883Article

Cancer Mucosa Antigens as a Novel Immunotherapeutic Class of Tumor-associated AntigenSNOOK, A. E; EISENLOHR, L. C; ROTHSTEIN, J. L et al.Clinical pharmacology and therapeutics. 2007, Vol 82, Num 6, pp 734-739, issn 0009-9236, 6 p.Article

The universal character of the tumor-associated antigen survivinHALD ANDERSEN, Mads; MARIE SVANE, Inge; BECKER, Jurgen C et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 5991-5994, issn 1078-0432, 4 p.Article

Haemangiopericytomas : the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA)àYU, C. C.-W; HALL, P. A; FLETCHER, C. D. M et al.Histopathology. 1991, Vol 19, Num 1, pp 29-33, issn 0309-0167Article

Serum TAG 72 levels in different human carcinomasCORREALE, M; ABBATE, I; GARGANO, G et al.International journal of radiation applications and instrumentation. Part B. Nuclear medicine and biology. 1991, Vol 18, Num 1, pp 101-103, issn 0883-2897Conference Paper

  • Page / 213